516 related articles for article (PubMed ID: 32148103)
21. Effect of HMG CoA reductase inhibitors on the development of chronic lung allograft dysfunction.
Szczepanik A; Hulbert A; Lee HJ; Benedetti C; Snyder L; Byrns J
Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29151274
[TBL] [Abstract][Full Text] [Related]
22. Changes in serum KL-6 levels are associated with the development of chronic lung allograft dysfunction in lung transplant recipients.
Bessa V; Bonella F; Ohshimo S; Weinreich G; Kleibrink B; Costabel U; Aigner C; Kamler M; Taube C; Sommerwerck U
Transpl Immunol; 2019 Feb; 52():40-44. PubMed ID: 30391371
[TBL] [Abstract][Full Text] [Related]
23. Lung volumes predict survival in patients with chronic lung allograft dysfunction.
Kneidinger N; Milger K; Janitza S; Ceelen F; Leuschner G; Dinkel J; Königshoff M; Weig T; Schramm R; Winter H; Behr J; Neurohr C
Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28404648
[TBL] [Abstract][Full Text] [Related]
24. Detection of chronic lung allograft dysfunction using ventilation-weighted Fourier decomposition MRI.
Voskrebenzev A; Greer M; Gutberlet M; Schönfeld C; Renne J; Hinrichs J; Kaireit T; Welte T; Wacker F; Gottlieb J; Vogel-Claussen J
Am J Transplant; 2018 Aug; 18(8):2050-2060. PubMed ID: 29607606
[TBL] [Abstract][Full Text] [Related]
25. Disease progression in patients with the restrictive and mixed phenotype of Chronic Lung Allograft dysfunction-A retrospective analysis in five European centers to assess the feasibility of a therapeutic trial.
Gottlieb J; Verleden GM; Perchl M; Valtin C; Vallee A; Brugière O; Bravo C
PLoS One; 2021; 16(12):e0260881. PubMed ID: 34941934
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of current strategies for surveillance and management of donor-specific antibodies: Single-center study.
Sullivan D; Ahn C; Gao A; Lacelle C; Torres F; Bollineni S; Banga A; Mullins J; Mohanka M; Ring S; Wait M; Peltz M; Duddupudi P; Surapaneni D; Kaza V
Clin Transplant; 2018 Jul; 32(7):e13285. PubMed ID: 29774598
[TBL] [Abstract][Full Text] [Related]
27. Effect of adherence to home spirometry on bronchiolitis obliterans and graft survival after lung transplantation.
Kugler C; Fuehner T; Dierich M; DeWall C; Haverich A; Simon A; Welte T; Gottlieb J
Transplantation; 2009 Jul; 88(1):129-34. PubMed ID: 19584692
[TBL] [Abstract][Full Text] [Related]
28. Long-Term Impact of Cytomegalovirus Serologic Status on Lung Transplantation in the United States.
Kurihara C; Fernandez R; Safaeinili N; Akbarpour M; Wu Q; Budinger GRS; Bharat A
Ann Thorac Surg; 2019 Apr; 107(4):1046-1052. PubMed ID: 30476471
[TBL] [Abstract][Full Text] [Related]
29. Montelukast in chronic lung allograft dysfunction after lung transplantation.
Vos R; Eynde RV; Ruttens D; Verleden SE; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck DE; Verleden GM;
J Heart Lung Transplant; 2019 May; 38(5):516-527. PubMed ID: 30638839
[TBL] [Abstract][Full Text] [Related]
30. Long-Term Off-Line Extracorporeal Photochemotherapy in Patients with Chronic Lung Allograft Rejection Not Responsive to Conventional Treatment: A 10-Year Single-Centre Analysis.
Del Fante C; Scudeller L; Oggionni T; Viarengo G; Cemmi F; Morosini M; Cascina A; Meloni F; Perotti C
Respiration; 2015; 90(2):118-28. PubMed ID: 26112178
[TBL] [Abstract][Full Text] [Related]
31. Impact of chronic lung allograft dysfunction, especially restrictive allograft syndrome, on the survival after living-donor lobar lung transplantation compared with cadaveric lung transplantation in adults: a single-center experience.
Sugimoto S; Yamamoto H; Kurosaki T; Otani S; Okazaki M; Yamane M; Toyooka S; Oto T
Surg Today; 2019 Aug; 49(8):686-693. PubMed ID: 30790054
[TBL] [Abstract][Full Text] [Related]
32. Association between cytomegalovirus viremia and long-term outcomes in lung transplant recipients.
Kawashima M; Ma J; Huszti E; Levy L; Berra G; Renaud-Picard B; Takahagi A; Ghany R; Sato M; Keshavjee S; Singer L; Husain S; Kumar D; Tikkanen J; Martinu T
Am J Transplant; 2024 Jun; 24(6):1057-1069. PubMed ID: 38307417
[TBL] [Abstract][Full Text] [Related]
33. Chronic lung allograft dysfunction phenotype and prognosis by machine learning CT analysis.
McInnis MC; Ma J; Karur GR; Houbois C; Levy L; Havlin J; Fuchs E; Tikkanen J; Chow CW; Huszti E; Martinu T
Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 34949699
[TBL] [Abstract][Full Text] [Related]
34. Immediate postoperative inflammatory response predicts long-term outcome in lung-transplant recipients.
Hall DJ; Baz M; Daniels MJ; Staples ED; Klodell CT; Moldawer LL; Beaver TM
Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):603-7. PubMed ID: 22815323
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction.
Levy L; Moshkelgosha S; Huszti E; Hunter S; Renaud-Picard B; Berra G; Kawashima M; Fernandez-Castillo J; Fuchs E; Dianti M; Ghany R; Keshavjee S; Singer LG; Tikkanen J; Martinu T
J Heart Lung Transplant; 2023 Aug; 42(8):1152-1160. PubMed ID: 36963446
[TBL] [Abstract][Full Text] [Related]
36. Restrictive allograft dysfunction rather than bronchiolitis obliterans syndrome had a major impact on the overall survival after living-donor lobar lung transplantation.
Matsubara K; Otani S; Yamamoto H; Hashimoto K; Tanaka S; Shien K; Suzawa K; Miyoshi K; Yamamoto H; Okazaki M; Sugimoto S; Toyooka S
Surg Today; 2024 Apr; 54(4):317-324. PubMed ID: 37523071
[TBL] [Abstract][Full Text] [Related]
37. Prophylactic Azithromycin Therapy After Lung Transplantation: Post hoc Analysis of a Randomized Controlled Trial.
Ruttens D; Verleden SE; Vandermeulen E; Bellon H; Vanaudenaerde BM; Somers J; Schoonis A; Schaevers V; Van Raemdonck DE; Neyrinck A; Dupont LJ; Yserbyt J; Verleden GM; Vos R
Am J Transplant; 2016 Jan; 16(1):254-61. PubMed ID: 26372728
[TBL] [Abstract][Full Text] [Related]
38. Primary graft dysfunction grade 3 following pediatric lung transplantation is associated with chronic lung allograft dysfunction.
Wong W; Johnson B; Cheng PC; Josephson MB; Maeda K; Berg RA; Kawut SM; Harhay MO; Goldfarb SB; Yehya N; Himebauch AS
J Heart Lung Transplant; 2023 May; 42(5):669-678. PubMed ID: 36639317
[TBL] [Abstract][Full Text] [Related]
39. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
[TBL] [Abstract][Full Text] [Related]
40. Outcome of lung transplantation in non-idiopathic pulmonary fibrosis interstitial lung disease.
Bode H; Verleden SE; Wuyts WA; Yserbyt J; Verleden GM; Vos R
Clin Transplant; 2019 Oct; 33(10):e13661. PubMed ID: 31286560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
